Amylyx Pharmaceuticals, Inc. (AMLX)

NASDAQ: AMLX · Real-Time Price · USD

21.43

-0.20 (-0.92%)

At close: Aug 17, 2026, 4:00 PM EDT

24.70

+3.27 (15.26%)

After-hours: Aug 17, 2026, 4:12 PM EDT

Amylyx Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	-	87.37	380.79	22.23	0.29
Revenue Growth	-	-	-77.05%	1612.94%	7700.00%	-56.15%
Cost of Revenue	90.85	90.4	228.72	153.63	96.44	44.04
Gross Profit	-90.85	-90.4	-141.35	227.16	-74.21	-43.76
Selling, General & Admin	69.66	62.89	114.33	188.36	127.13	38.93
Operating Expenses	71.25	62.89	114.33	188.36	127.13	38.93
Operating Income	-162.1	-153.29	-255.68	38.8	-201.34	-82.69
Interest & Investment Income	10	9.3	13.81	16.16	4.29	0.04
Other Non Operating Income (Expenses)	-6.23	-6.23	-11.07	-10.6	-2.61	0.07
EBT Excluding Unusual Items	-157.57	-150.22	-252.94	44.36	-199.66	-82.58
Merger & Restructuring Charges	-	-	-22.85	-	-	-
Gain (Loss) on Sale of Investments	5.53	5.53	9.86	9.94	2.06	-0.12
Other Unusual Items	-	-	-	-	-	-5.23
Pretax Income	-152.05	-144.69	-302.14	54.3	-197.6	-87.93
Income Tax Expense	0.05	0.05	-0.39	5.03	0.77	-
Net Income	-152.09	-144.74	-301.74	49.27	-198.38	-87.93
Net Income to Common	-152.09	-144.74	-301.74	49.27	-198.38	-87.93
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	106	95	68	67	58	7
Shares Outstanding (Diluted)	106	95	68	70	58	7
Shares Change	36.47%	38.78%	-2.64%	19.65%	788.13%	8.37%
EPS (Basic)	-1.43	-1.53	-4.43	0.73	-3.39	-13.35
EPS (Diluted)	-1.43	-1.53	-4.43	0.70	-3.39	-13.35
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-126.72	-123.48	-204.01	10.68	-182.4	-75.15
Free Cash Flow Per Share	-1.19	-1.31	-2.99	0.15	-3.12	-11.41
Gross Margin	-	-	-161.78%	59.66%	-	-
Operating Margin	-	-	-292.63%	10.19%	-905.72%	-29013.33%
Profit Margin	-	-	-345.36%	12.94%	-892.38%	-30852.98%
Free Cash Flow Margin	-	-	-233.50%	2.80%	-820.50%	-26369.12%
EBITDA	-161.73	-152.77	-254.77	39.89	-200.85	-82.64
EBITDA Margin	-	-	-291.60%	10.48%	-	-
D&A For EBITDA	0.37	0.53	0.9	1.09	0.49	0.05
EBIT	-162.1	-153.29	-255.68	38.8	-201.34	-82.69
EBIT Margin	-	-	-292.63%	10.19%	-	-
Effective Tax Rate	-	-	-	9.26%	-	-
Revenue as Reported	-	-	-	-	22.23	0.29
Advertising Expenses	-	-	-	9.5	4.4	-

SEC Filings: 10-K · 10-Q